Neurodegenerative Disease

LONDON, May 14, 2026 AviadoBio presented new preclinical data at the American Society of Gene and Cell Therapy (ASGCT)...

SHANGHAI and SEONGNAM-SI, South Korea, May 13, 2026 Fosun Pharma and AriBio announced the signing of an exclusive global...

PARIS and CAMBRIDGE, UK, May 13, 2026 AndzonBio2 announced a strategic collaboration with the ALBORADA Drug Discovery Institute (ADDI)...

BOSTON, Mass., May 12, 2026 Tolion Health AI has announced the launch of the latest version of its Tolion...

BASEL, Switzerland, May 12, 2026 Roche announced that it has received European CE Mark approval for Elecsys® plasma phosphorylated-tau...

NEW YORK, May 11, 2026 Myrtelle announced new clinical and regulatory updates for its investigational gene therapy candidate MYR-101...

TOKYO and CAMBRIDGE, Mass., May 8, 2026 Eisai Co., Ltd. and Biogen Inc. announced that the U.S. Food and...

JACKSONVILLE, FL, May 04, 2026 Medical Microinstruments (MMI) has successfully treated the first patient in its FDA-approved REMIND clinical...

PASADENA, Calif., April 28, 2026 AcuraStem has received $7.5 million in grant funding from the California Institute for Regenerative...

PHILADELPHIA & BOSTON, April 28, 2026 Latus Bio, Inc. has announced new preclinical and computational data supporting its investigational...